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Abstract 
Cell membrane engineering is an emerging approach in the field of tissue engineering which 
aims to exploit the modification of cell membranes for a variety of applications including cell 
homing and retention, stem cell-tethered biosensors, and  cell-mediated drug delivery.  
Compared to procedures requiring genetic manipulation, cell membrane engineering may 
exhibit several advantages such as decreased cell manipulation, a decreased effect on cell 
viability and proliferation, and a quicker translation towards in vivo studies.  In particular, the 
ability to systematically manipulate the chemistry of cell membranes could form the basis for 
new investigations into cell functions, including most notably, the analysis of cell-
microenvironment interactions.  Further, the combination of cell membrane engineering with the 
optimization of biomaterial scaffold encapsulation techniques could potentially provide 
unprecedented control of cell-biomaterial interfaces which are critical in defining cellular 
processes such as stem cell differentiation. 
 
This Thesis describes the development and optimization of methods for the conjugation of 
biomaterial polymers to the membrane of pluripotent stem cells (mouse embryonic stem cells).  
Such methods have not previously been reported for embryonic stem cells, and thus, we aimed 
to establish with this work a foundation for future applications aimed at cell labeling or the 
defined modulation of cell functions. 
 
In order to perform quantitative analysis of stem cell membrane conjugation procedures we 
primarily employed a flow cytometry based approach utilizing fluorescently labeled biomaterial 
components.  Specifically, we examined the efficiency of NHS-based biomaterial conjugation, 
the efficiency of an unexpected acrylate-based conjugation finding, and the combinatorial 
effects of UV light exposure.  In addition, we systematically optimized dosage effects and 
explored the potential influence of biomaterial conjugation on cell viability as well as the 
retention of biomaterial domains during stem cell culture.  The presented studies demonstrate 
that embryonic stem cells can be effectively modified on their cell membrane without 
significantly affecting cell function and expansion.   Future experiments building on this work will 
be focused towards the further elucidation of the functional groups present on the membrane of 
embryonic stem cells and an improved understanding of the mechanisms underlying membrane 
conjugation approaches.  Overall, these efforts establish a modular method for manipulating 
stem cells which could serve as an enabling technology for influencing stem cell functions in 
numerous tissue engineering contexts. 
 
 
iii 
 
 
 
 
 
 
 
 
 
 
 
 
To my parents, for their love and support 
 
 
iv 
ACKNOWLEDGEMENTS 
I would first like to thank my adviser, Professor Gregory Underhill, for being a great 
mentor and allowing me the opportunity to be a member of his lab group to pursue my 
academic interests. This work represents a long process of support, guidance, and 
innovation on his part. Despite several setbacks, Dr. Underhill’s continual motivation 
and attention to detail proved invaluable for the project’s development. Thank you also 
for listening and the continual feedback both academically and personally. 
 
I would also like to recognize the entire Underhill Lab group for their encouragement 
and for teaching me many of the laboratory techniques required for this project. I would 
especially like to thank Ravi C. Yada for aiding me with the extensive stem cell culture, 
the lengthy flow cytometry experiments, and in general, for his continual excitement for 
the project. 
 
I also thank Dr. Barbara Pilas for her support academically and personally. I would also 
like to thank the Biotechnology Center for access to the flow cytometers. 
 
Most importantly, I would like to thank my parents, Satish and Rama, and my siblings, 
Rajani and Neal, for their love and support. Thank you for giving me the confidence for 
completing this process and never losing faith in me.  
 
Lastly, I thank Shamira Sridharan, Shaneen Braswell, and Yanfen Lee for always being 
there when I needed them, and for their continual encouragement and moral support.  
 
I am also grateful for the funding provided by the National Science Foundation 
Integrative Graduate Education and Research Traineeship, ‘Training the Next 
Generation of Researchers in Cellular and Molecular Mechanics and 
BioNanotechnology’ (CMMB IGERT, Grant 0965918). 
 
 
 
Table of Contents 
CHAPTER 1 INTRODUCTION ................................................................................................... 1 
1.1 INTRODUCTION.................................................................................................................... 1 
1.2 OVERALL GOAL AND SPECIFIC AIMS ..................................................................................... 3 
CHAPTER 2 BACKGROUND ..................................................................................................... 4 
2.1 THE STEM CELL MICROENVIRONMENT .................................................................................. 4 
2.2 STEM CELL ENCAPSULATION ................................................................................................ 6 
2.3 CELL MEMBRANE ENGINEERING APPLICATIONS ................................................................... 10 
CHAPTER 3 STEM CELL CULTURE METHODS .................................................................... 13 
3.1 INTRODUCTION .................................................................................................................. 13 
3.2 CULTURE AND PREPARATION OF MEF FEEDER LAYERS ....................................................... 13 
3.3 CULTURE OF MOUSE ES CELLS .......................................................................................... 14 
3.3 MEF DEPLETION AND PREPARATION FOR MEMBRANE LABELING .......................................... 15 
CHAPTER 4 NHS-BASED MEMBRANE CONJUGATION OF MOUSE EMBRYONIC STEM 
CELLS ...................................................................................................................................... 16 
4.1 INTRODUCTION .................................................................................................................. 16 
4.2 EXPERIMENTAL APPROACH ................................................................................................ 16 
4.3 RESULTS........................................................................................................................... 18 
4.4 DISCUSSION ...................................................................................................................... 20 
CHAPTER 5 DOSAGE-DEPENDENT EFFECTS ON LABELING EFFICIENCY ...................... 21 
5.1 INTRODUCTION .................................................................................................................. 21 
5.2 EXPERIMENTAL APPROACH ................................................................................................ 21 
5.3 RESULTS........................................................................................................................... 22 
5.4 DISCUSSION ...................................................................................................................... 24 
CHAPTER 6 RETENTION OF BIOMATERIAL LABELING IN SELF-RENEWING ES 
CULTURE ................................................................................................................................. 25 
6.1 INTRODUCTION .................................................................................................................. 25 
6.2 EXPERIMENTAL APPROACH ................................................................................................ 25 
6.3 RESULTS........................................................................................................................... 26 
6.4 DISCUSSION ...................................................................................................................... 29 
CHAPTER 7 ACRYLATE-BASED MEMBRANE CONJUGATION & RETENTION  ................. 30 
7.1 INTRODUCTION .................................................................................................................. 30 
7.2 EXPERIMENTAL APPROACH ................................................................................................ 31 
7.3 RESULTS........................................................................................................................... 32 
7.4 DISCUSSION ...................................................................................................................... 37 
CHAPTER 8 CONCLUSION AND FUTURE DIRECTIONS ...................................................... 40 
REFERENCES ......................................................................................................................... 41 
 
 
 
1 
Chapter 1 Introduction 
1.1 Introduction  
Tissue and organ failure is a major health problem within the United States. According to 
the United Network for Organ Sharing, more than 117,000 Americans are waiting for an 
organ transplant, but there are only approximately 20,000 organs available each year. 
To address these concerns, the field of tissue engineering is rapidly becoming a 
potential alternative, or at least a complementary solution, to transplantation. 
Researchers are able to implant natural, synthetic, or semisynthetic tissue and organs 
that are either fully functional from the start or will eventually grow into the required 
functionality. There are various methods by which to achieve this goal ranging from 
focusing on using skin equivalents to biomaterials to scaffolds (Nature Biotech, 2000). 
However, a limitation to these methods can include immunogenicity, rejection, and of 
course the difficulty of growing specific cell types in large quantities (Koh, 2004). A 
potential solution to these concerns is the combination of different approaches with stem 
cells to differentiate stem cells into the desired cell type (Figure 1). Along with the ability 
to differentiate into many specialized cell types, stem cells also maintain the ability to 
proliferate in an undifferentiated but pluripotent state (Brivanlou, 2003). This makes stem 
cells an ideal choice for our specific interests.  
 
Elaborating on Figure 1, there are currently two main approaches for directing stem cell 
differentiation: in vitro directed differentiation and reprogramming. In the first approach, 
pluripotent stem cells are generally placed in an in vitro environment that is similar to the 
desired cell type environment. By mimicking both the natural environment and 
differentiation steps, a specific desired cell type can be produced in an in vitro setting 
prior to implantation back into a human. Some methods to achieve this controlled in vitro 
differentiation include the addition of recombinant growth factors to differentiation media 
of cells in culture, variations in the intensity of signaling molecules in media, small 
chemical molecules to enhance, inhibit, or substitute a specific factor in the signaling 
pathway, formation of embryoid bodies, and finally, the use of co-culture systems. In the 
latter approach, one fully differentiated cell type can be converted directly into another 
through the expression of key transcription factors in viral expression constructs. 
However, there are some challenges to these current approaches.  
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Some of these challenges include low efficiency in the production of desired cell 
generation, difficulty in adapting methods used with mouse cells for human cells, and of 
course, the safety and cost concerns from the reagents used to direct cell fate. For 
example, reagents used for in vitro purposes often contain animal products which can 
introduce compatibility and immunogenicity concerns if the produced cells are 
transplanted into humans. Also, even though chemical factors appear to be more 
beneficial over biological ones, it has been difficult to actually determine their 
mechanism of action. One specific challenge with the directed differentiation approach is 
that immature cells with embryonic or early postnatal phenotypes may be produced 
rather than true adult cells. This may occur due to the fact that cells are in culture for 
several weeks while cells in the body are developed for a much longer time (Cohen, 
2011). The specific challenge with reprogramming is the use of viruses which 
permanently integrate into the host genome. There are some alternative methods being 
developed to address these concerns, but they are not as efficient as the viral vector 
method. Despite being a highly beneficial idea for regenerative medicine with promising 
results, more work must be completed to determine a more compatible, price efficient, 
and reliable method for stem cell differentiation.  
 
An emerging solution within the tissue engineering field is that of cell membrane 
engineering (CME). CME refers to the modification of a cell membrane through 
biological, chemical, or physical methods to alter cellular functions. Engineering cells to 
present natural or synthetic ligands on their membrane has becoming a promising way 
to control and understand cell-microenvironment interactions, cell-cell events, cellular 
adhesion, and signal transduction (Cheng, 2013; Mahal, 1997). Some examples of CME 
include cell-mediated drug delivery, cell homing and retention, and stem cell-tethered 
biosensors. However, most of these stem cell approaches have been studied mainly 
with mesenchymal stem cells (MSCs) or hematopoietic stem cells (HSCs). There has 
been little exploration in CME with utilizing pluripotent stem cells for different applications, 
specifically for understanding or directing differentiation. This idea prompts further 
exploration to potentially develop a new method that does not require manipulation of 
the cell from the inside for directing stem cell differentiation, thereby addressing some of 
the previous concerns.  In this Thesis, we investigate several approaches for introducing 
defined biomaterial components to the cell membrane of pluripotent stem cells. 
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Figure 1: Schematic showing the two current approaches (reprogramming and directed 
differentiation) to differentiate stem cells to the desired cell types for transplantation back into 
humans in tissue engineering/regenerative medicine (Cohen, 2011) 
 
 
 
 
1.2 Overall Goal and Specific Aims 
Our overall goal in this work was to develop an approach for introducing defined 
biomaterial moieties to the cell surface membrane of stem cells.  These efforts would 
enable the modulation of cell-biomaterial interfaces and ultimately could be applied 
towards the analysis and optimization of microenvironmental interactions that regulate 
directed differentiation/reprogramming.  Two specific steps towards accomplishing this 
overall goal will be further discussed in this Thesis. In Specific Aim 1, we investigated 
the capability of introducing synthetic biomaterial functional groups, specifically NHS-
based biomaterials, to the surface membrane of embryonic stem (ES) cells.  In these 
experiments, we examined the effects of biomaterial linker concentration on cell labeling 
efficiency, cell viability, and retention in self-renewing culture.  In addition, in Specific 
Aim 2, we systematically explored an unexpected finding of these studies in which 
acrylate-based biomaterials exhibited cell surface conjugation capability which could be 
partially modulated by UV light exposure.  Collectively, these studies described here 
provide the foundation for future efforts aimed at the deconstructing cell surface 
conjugation mechanisms and exploiting these methods for novel applications in tissue 
engineering.  
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Chapter 2 Background  
2.1 The Stem Cell Microenvironment  
Stem cell responses, such as their ability to differentiate and self-renew, depend on the 
cell’s microenvironment, or niche. The niche is important as it maintains stem cells in 
quiescence and a low metabolic state to prevent stem cell exhaustion. The niche also 
protects stem cells from accumulating gene mutations (Gattazo, 2014). The 
microenvironment is composed of various chemical and physical signals that interlink to 
regulate the fundamental stem cell processes. These signals are generally a result of 
different soluble factors, such as growth factors or hormones, or insoluble factors, such 
as cell-cell interactions, cell-extracellular matrix interactions, or surface-bound signaling 
molecules (Underhill, 2012). Physical forces exerted on the cell or even the shape of a 
cell could also modulate the signals in various ways. Intrinsic genetic pathways then 
regulate these extrinsic signals and determine the cell’s response to a specific signal. 
Aside from self-renewal and differentiation, some of the other fundamental processes 
include: apoptosis, migration, or biosynthesis/metabolism (Zhang, 2008; Metallo, 2007). 
The inputs from the microenvironment and its consequent effects can be seen in 
Figure 2.  
 
The major component of a stem cell’s microenvironment is the extracellular matrix 
(ECM). The ECM is able to either directly or indirectly regulate the cell behavior and 
plays essential roles during development. ECM’s physical properties such as rigidity, 
porosity, topography, and insolubility effect cell division, tissue polarity, and cell 
migration (Gattazo, 2014). These physical properties play a significant role in engineered 
microenvironments. The ECM’s biochemical properties, specifically ECM stiffness, also 
influences cell behavior since cells sense these external forces and respond accordingly. 
Cell-ECM interactions can be mediated by cell receptors, such as integrins, and play a 
significant role in the adhesion, anchorage, and homing of stem cells. To investigate the 
specific functions of different ECM components in stem cell niches, in vivo studies are 
ideal. However, the niche is so complex and there are many different factors which play 
simultaneous roles, that these studies become very complex and difficult. 
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One way to address the previous challenge and understand the effect of the 
microenvironment on cellular responses is through in vitro engineered 
microenvironments. Engineered microenvironments have been increasingly successful 
in controlling stem cell fate by mimicking the key regulatory signals from native stem cell 
microenvironments. The different engineered microenvironment methods include 
micropatterning, high-throughput arrays, bioreactors/microfluidics, and computational 
models (Metallo, 2007). The specific engineered microenvironment that we are 
interested in exploring further is the culturing of cells in confined areas, such as in 
alginate or agarose beads or even three-dimensional (3D) polymer scaffolds or 
hydrogels. 
 
Elaborating on some of the different approaches, micropatterning can be used to control 
specific cell positioning, shape, and exposure to ECM proteins in two dimensional (2D) 
cultures. The ECM proteins are patterned on a surface with a micrometer resolution. 
This technique has been used prominently to investigate the influence of cell shape and 
cell-ECM interactions. In another method, PDMS stamps can be used to mold 
microwells using hydrogels composed of agarose, polyacrylamide, or poly(ethylene 
glycol) (PEG). These microwells are typically used for high-throughput analysis to better 
understand cell-cell interactions. Combining both the microwell and micropatterning 
approaches, researchers have also been able to from ES cell aggregates with tightly 
controlled diameters to understand the roll of cell-cell interactions in ES cell 
differentiation. To also examine ES cell differentiation, PDMS can be molded into an 
array of vertical posts over which cells can be cultured. Depending on the height of these 
vertical posts, the substrate rigidity will be different, thus providing a different 
environment for the stem cells. For example, short vertical posts have a stiff environment 
while a taller vertical post will mimic a soft environment. These micropillars also allow for 
a greater understanding of ES cell differentiation in respect to traction force, focal 
adhesions, and cytoskeletal tension. Another high-throughput analysis makes use of 
cellular microarrays. The microarrays consist of either printed spots of biomolecules with 
cells seeded on top or direct live cells encapsulated in hydrogel droplets to study the role 
of combinations of different ECM proteins in cell processes. Again, providing another 
technique to understand how differentiation is regulated by combinatorial signals 
(Underhill, 2012). This can also be understood computationally using statistical methods 
and network models. 
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To understand the effects of the mechanical properties from the microenvironment on 
stem cells, hydrogels can also be chemically modified to present either native ECM 
proteins or adhesive peptides. Hydrogels, especially PEG-based systems, can be tuned 
based on porosity and mechanical properties. They can also be co-encapsulated or 
conjugated with bioactive factors to add biological functionality in a controlled manner. I 
will further discuss hydrogels specifically for stem cell encapsulation methods, in the 
following section.  
 
 
2.2 Stem Cell Encapsulation  
As previously mentioned, hydrogels are one type of encapsulation method to mimic a 
cell’s microenvironment. The most common type of hydrogel used for these studies are 
PEG hydrogels. PEG hydrogels can act as matrices for the controlled release of 
biomolecules or even as scaffolds for regenerative medicine. The primary advantage of 
using hydrogels is that not only can they simultaneously encapsulate cells and various 
biomolecules and are biocompatible, but they also allow one to control the release of 
Figure 2: Schematic displaying the various cellular responses resulting from different 
microenvironmental inputs (Metallo, 2007) 
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biomaterials through systematic changes in the gel’s physical and chemical structure 
(Lin, 2008). 
 
PEG hydrogels can be formed by various methods of gelation, such as by physical, ionic, 
or covalent interactions, but it is the different chemical or covalent-crosslinking leads that 
form the stable hydrogel structures. This in turn allows for tunable physicochemical 
properties, such as permeability, molecular diffusivity, equilibrium water content, 
elasticity, and degradation rate. When degradable linkers are introduced to the covalent 
crosslinks, it allows for the fabrication of well-defined network structures with adaptable 
properties in time. For our particular purpose, the synthesis of covalently crosslinked 
PEG gel networks is caused by a chain-growth crosslinking reaction mechanism 
(Figure 3a). These networks are generally formed from functional PEG molecules, such 
as PEG-di(meth)acrylate (Figure 3b), which is what we want to accomplish in Aim 2. 
Polymerization is caused by free radicals generated from redox reactions or from the 
photocleavage of initiator molecules. The propagation of these radicals through multiple 
carbon-carbon double bonds on PEG monomers results in covalently crosslinked chains. 
The advantage of using a photopolymerization method to form stable hydrogels is that 
this process takes simply a few minutes. This reduces exposure of biomaterials to 
thermal energy which in turn reduces negative effects on proteins and cells drastically 
(Lin, 2008).  
 
Hydrogels can also serve as an ideal model for studying controlled stem cell 
differentiation. Since, as previously mentioned, stem cells are naturally surrounded by a 
matrix that provides biochemical signals and a structure for physical cell-matrix 
interactions to occur (Vincent, 2013). A hydrogel, or even a hydrogel-like system, can 
mimic this type of environment. There are different ways to achieve this differentiation. 
One can incorporate bioactive molecules with PEG-based hydrogels or one can even 
retain cell-secreted biomolecules with the hydrogels. The benefits of the latter are that it 
can be utilized only when needed, such as during differentiation processes, and their 
bioactivity could have a greater effect than synthetic analogs which are covalently 
incorporated within the gel environment (Lin, 2008). As shown with alginate hydrogels, 
stem cell differentiation was found to be either directly influenced by the cell’s ability to 
deform rigid substrates or indirectly affected by the cells first degrading the matrix and 
then contracting it. As can be seen in Figure 3c, the chemistry and mechanics of cell-
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biomaterial interactions can also significantly influence stem cell differentiation. The 
chemical conjugation of polymer chains to stem cell membranes could potentially play 
an important role. For our overall goal, we aim to find an intermediate solution and 
develop an approach for modulating cell-biomaterial interactions within 3D hydrogel 
scaffolds. 
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A) 
B) 
Figure 3:  Schematic displaying a) PEG hydrogels formed by the chain-growth method b) the 
chemical structure of PEG and di(meth)acrylate derivatives that form the  hydrogel networks 
for cell encapsulation (Lin, 2008) and c) how cell traction forces can affect the clustering of 
polymer chains to membranes in hydrogels which in turn effects stem cell differentiation 
(Vincent, 2008) 
C) 
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2.3  Cell Membrane Engineering Applications  
CME controls different cell-microenvironment interactions that regulate many biological 
events and play a critical role in tissue regeneration. There are many applications for 
stem cell membrane engineering resulting from microenvironmental interactions, some 
examples of which can be seen in Figure 4.  
 
One such example includes cell homing and retention, which is the navigation of cells, 
such as stem cells, to targeted tissues, for example, injured tissues. Human bone 
marrow-derived mesenchymal stem cells (hMSCs) target receptors are expressed on 
inflamed vessels of injured tissues.  Specifically, inflammatory cytokine-activated 
endothelial cells express adhesion molecules that induce the rolling of leukocytes and 
recruit them to the inflamed tissues. The endothelial cells also express vascular cell 
adhesion molecules which allow for firm adhesion of leukocytes. In the paper by Cheng 
et al., the research team modified the membrane surfaces of the hMSCs to conjugate 
synthetic ligands (E-selectin targeting peptides) to control the binding of stem cells on 
adhesion molecules. By modifying the kinetics of the interaction between peptides and 
selectins, they were able to engineer hMSCs to firmly adhere or roll under 
physiologically relevant shear stresses. For example, in one of their tests, they found 
that stem cells modified with peptides that strongly bind to selectins remain bound under 
physiological flow and do not roll, while peptides that bind to selectins with fast 
dissociation rate constant roll in the direction of flow. Overall, they found that their 
approach did not affect cell viability, proliferation, or multipotency, but it did open the 
doors for cell homing and retention in other diseases/instances (Cheng, 2012). 
 
Another example for a CME application is the modification of stem cell membranes to 
tether biosensors to better understand cell signaling and cell-to-cell communication, 
especially in real time. This allows for a greater understanding and tracking of 
transplanted cells; once again of cell homing to sites of inflammation. Specially, Zhao et 
al covalently attached fluorescent nucleic acid aptamer sensors with surface anchoring 
moieties to the surface of cells to produce a real-time signal when target molecules 
(platelet-derived growth factors [PDGF]) contact the cell surface (MSCs). Upon contact, 
the PDGF sensor brings two attached dyes within close proximity and a fluorescence 
signal is produced which is then detected in real time. By using this simple method of 
 
 
11 
CME, there is no need for complex genetic engineering approaches and this application 
already has potential for in vivo applications. This method is also significant because it 
allows for the understanding of cellular response to cues in the microenvironment in both 
time and space (Zhao, 2011).  
 
The final example I will discuss is that of cell-mediated drug delivery by CME methods. 
In this application, adjuvant drug-loaded nanoparticles are conjugated to the surfaces of 
HSCs and T cells. In Stephan et al, this was done so by cell-surface thiols. In general, 
cell-mediated delivery allows for maximum donor cell efficacy and in vivo persistence, 
the offset of suppressive molecules at cell homing sites, and the promotion of 
differentiation of transferred cells into a therapeutically optimal phenotype. Using this 
particular method, Stephan et al showed that adjuvant agent-releasing particles can be 
stably conjugated to cells without toxicity or interference with intrinsic cell functions, 
mimic in vivo migration patterns of the carrier cell, and the carrier cell has enhanced 
function using low drug doses that typically have no effect when given by traditional 
systemic routes (Stephan, 2010). 
 
As was mentioned, CME methods are less complex than current procedures, such as 
genetic engineering or cancer immunotherapy. For example, with cancer immunotherapy 
methods, adjuvant drugs are necessary to maximize and maintain high levels of 
therapeutic cell efficacy. With genetic engineering, there are regulatory and cost barriers 
related to large-scale production, costly and lengthy protocols, technical challenges, and 
necessary small-molecule drugs that cannot be genetically encoded (Stephan, 2010). 
CME provides an alternative to these current approaches and addresses many of 
previously stated concerns while making CME a step closer to in vivo procedures. This 
makes cell membrane engineering a desirable approach and the one which we chose to 
combine with our embryonic stem cells to modulate cell-biomaterial interactions for 
differentiation.  
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A) 
B) 
C) 
Figure 4: Three different cell membrane engineering applications: a) human mesenchymal 
stem cell recruitment to injured tissues (Cheng, 2012), b) covalent attachment of 
fluorescent nucleic acid aptamer sensors with surface anchoring moieties to 
mesenchymal stems cells thus creating a stem cell biosensor (Zhao, 2011), and c) 
drug-loaded nanoparticles conjugated to human stem cell membranes for cell-mediated drug 
delivery (Stephan, 2010) 
 
 
13 
Chapter 3 Stem Cell Culture Methods 
3.1 Introduction  
To investigate cell-biomaterial modular linkages to cell membrane surfaces, we utilize 
embryonic stem cells. This chapter provides a general methodology for the culture and 
preparation of embryonic stem cells for growth and membrane labeling. Specific 
culturing and final preparation methods for individual experiments will be discussed in 
further detail in the appropriate chapters. 
 
3.2 Culture and Preparation of MEF Feeder Layers  
The first step in this process is the expansion of the Mouse Embryonic Fibroblasts 
(MEFs). MEFs serve as a feeder layer for mouse embryonic stem cells (mESCs) thereby 
providing the cells with the nutrients they need for survival. MEFs also can provide 
factors that enhance the proliferation and maintain the undifferentiated states of 
embryonic stem cells (Xu, 2005).  
 
To expand MEF cells, first, six T150 culture flasks are coated with 7mL of 0.1% gelatin 
(dissolved in distilled water) and placed in an incubator (37ºC and 5% CO2) for 
15-20 minutes. During this time,         MEF cells (PMEF, Strain CF-1, Untreated, 
EMD Millipore) are thawed and resuspended in 12mL of MEF media. MEF media 
components include: 87.5% DMEM, 10% Fetal Bovin Serum (FBS), 0.5% 
Penicillin/Streptomycin, 1% L-glutamine, and 1% Minimum Essential Medium Non-
Essential Amino Acid (MEM NEAA). At the end of the time period, the gelatin is 
aspirated from the culture flasks and the flasks are washed once with 1X Phosphate 
Buffer Solution (PBS). To each flask, 23mL of MEF media and 2mL of the MEF cell 
suspension is added and then the flasks are placed back in the incubator to for MEF 
cells expansion. After about 1-2 days, the old media is aspirated and the fresh MEF 
media is added (25mL). At this stage, the MEF cells are generally ~35-40% confluent. 
1-2 days after this point, MEFs are usually ~80-90% confluent. This means that there is 
generally a single layer of growing MEF cells, with some overlap, coating most of the 
gelatin layer and the cells need to be growth arrested. 
 
For the growth arrest process, Mitomycin C (Sigma-Aldrich) is used.  Mitomycin C 
inhibits DNA synthesis by forming crosslinks between complementary strands of DNA so 
that the strands cannot separate. This in effect inhibits DNA replication and prevents the 
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MEF cells from growing (Verweij, 1990).  In our case, the light-sensitive Mitomycin C 
powder (2mg) is first reconstituted with 1X PBS (4mL) to obtain a working stock 
concentration of 0.5mg/mL and then sterilized with a syringe filter. The sterile Mitomycin 
C is further diluted to 10µg/mL with MEF media. The old culture media from the flasks is 
aspirated and 16.8mL of the Mitomycin C MEF media solution is added to each flask. 
The flasks are then placed back into the incubator for another ~3 hours. At the end of 
this time, the Mitomycin C MEF media solution is removed and the culture flask rinsed 
with sterile 1X PBS. 0.25% Trypsin is added to each culture flask and the cells are again 
placed back in the incubator for 5 min. As in regular cell culture, MEF media is added to 
stop the trypsin and the suspension is centrifuged (5 minutes at 1000 RPM). The 
supernatant is aspirated and the MEFs resuspended in ~10mL of MEF media. The cells 
are then counted and aliquoted (the cells were centrifuged after counting and 
appropriate volume of MEF freeze media (77.8% MEF media, 12.2% FBS, and 10% 
DMSO) added) so that there are approximately 1 million cells per cryovial (for a total of 
~7 cryovials). The cryovials are transferred to a freeze container and placed in the -80ºC 
fridge for ~24 hours. After about a day, the cryovials are transferred to a liquid Nitrogen 
tank. 
 
3.3 Culture of Mouse ES cells 
Similar to the MEF culture, gelatin (5mL) is added to two 10cm petri dishes and 
incubated for 15-20 minutes. During this time, a frozen vial of MEF cells are thawed in 
19mL of MEF media and centrifuged (for each petri dish). The supernatants are 
aspirated and the cells suspended in 10mL of MEF media each. At the end of the 15-20 
minutes, the gelatin layers are aspirated, washed, and the MEF cell suspensions are 
added. The petri dishes are both placed back in the incubator to allow the MEF cells to 
grow overnight.  
 
After about 24 hours, the MEF cells are generally ~95% confluent, with some cells 
overlapping. At this point, thaw a frozen vial of mESC and add it to ES growth media 
(82.3% DMEM, 15% ES-qualified FBS, 0.5% Penicillin/Streptomycin, 1% L-glutamine, 
1% MEM-NEAA, and 2mL of 2-mercaptoethanol in PBS from a stock solution of 50mM). 
Centrifuge this solution and aspirate the supernatant. The ES cells are resuspended in 
12mL of ES growth media with 12µL of Leukemia inhibitory factor (LIF, Millipore). LIF 
maintains mESCs in an undifferentiated state so it is important to add fresh LIF every 
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22-24 hours. Aspirate the MEF media from the MEF cells and rinse with sterile 1X PBS. 
After the PBS has been removed, add in the ES cell suspension to the MEF layer and 
incubate for ~22 hours. 
 
One day (~22 hours) after the ES cells have been plated, the confluency of the cells is 
normally ~5%. Again, the old media is aspirated and a fresh solution of ES media + LIF 
is added to the cells. After ~20 hours, the ES cells are generally ~25% confluent and the 
media is changed once again. By the third day, mESCs are generally ~75-80% confluent. 
It is at this point when mESCs are either typically frozen down or used for experiments. 
mESCs can also be passaged with no greater than 1/8 dilution on a new MEF feeder 
layer. 
 
3.4 MEF Depletion and Preparation for Membrane Labeling  
Once the mESCs reach ~75-80% confluency, they undergo a MEF depletion to isolate 
the mESCs from the MEF cells as this will ensure an accurate mESC cell number for the 
next step. For this depletion, the old media is aspirated from the mESCs, trypsin (6mL) 
added, and the cells are incubated. After 5 minutes, ES media is added to counteract the 
trypsin. The cells are centrifuged and the supernatant aspirated. The mESCs are then 
resuspended in 15mL of ES media and counted. If the cells will be frozen down, then 
freeze media (90% ES media and 10% DMSO) is added to the cell suspension and 
      cells + freeze media are added per cryovial (typically ~10 cryovials). The 
cryovials are transferred to a freeze container and placed in the -80ºC fridge for 
~24 hours. After about a day, the cryovials are transferred to a liquid Nitrogen tank. In 
terms of experiments, usually         mESCs are added to 9.4mL of ES media, but 
generally, the desired concentration is          cells/1mL ES media. It is at this 
concentration that the cells may be further divided for the appropriate experimental 
conditions and/or biomaterial added. However, as previously mentioned, the detailed 
membrane labeling methodology will be outlined in the applicable Experiment sections 
for the following chapters. 
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Chapter 4 NHS-Based Membrane Conjugation of Mouse Embryonic Stem 
Cells 
4.1 Introduction  
As mentioned in Chapter 1, we aim to develop an approach for modulating cell-
biomaterial linkages so that we can effectively guide their interactions with the 
microenvironment and thus direct stem cell differentiation. However, first, we must 
perform initial studies to better understand biomaterial attachment to cell membrane 
surfaces. It is essential to optimize the biomaterial concentration added to the stem cell 
surfaces that will be detectable on a single day, and ideally over the course of multiple 
days. This initial detection will introduce the possibility of a new CME method.  
 
4.2 Experimental Approach 
Initially, we tested a NHS-based biomaterial (NHS-PEG-Biotin, or NPB for short) on the 
surface of mouse embryonic stem cells (mESC). This system was chosen because 
1) NHS is known to form an amide bond with amines that are located on cell membrane 
surfaces and 2) biotin allows us to obtain a fluorescent readout based on biotin and 
fluorescent streptavidin chemistry (Biotin-Streptavidin Alexa Fluor 647 (SAF647) or 
Biotin-Streptavidin Alexa Fluor 488 (SAF488)). The actual fluorescent readout is 
obtained either quantitatively (flow cytometry (BD LSR)) or qualitatively (fluorescent 
microscope (Olympus IX81 Inverted Cell Culture Microscope)). The process used to 
label the biomaterial on the mESC surface can be seen in Figure 5.  
 
As mentioned above, one of techniques utilized to detect the conjugation of a biomaterial 
on the cell surface is flow cytometry. Flow cytometry measures the properties of single 
particles when they are in suspension. While in a tube, the particles are randomly 
scattered in 3D space, but a flow cytometer contains a fluidic system which allows a 
single file of particles to flow through the system. Specifically, the sample is injected into 
a central channel that is enclosed by an outer sheath containing faster flowing fluid. As 
the sheath fluid moves, it creates a drag effect on the narrowing central chamber which 
in turn alters the velocity of the central fluid so that the flow front becomes parabolic. 
This as a result creates the single file of particles. These particles then cross through a 
beam of lights and the light is scattered. Light that is scattered in the forward direction 
(FSC) provides information about the particle’s size and generally is used to determine 
the difference between debris and living cells. The side scatter channel (SSC) provides 
 
 
17 
information on the granularity of a particle. To analyze the flow cytometry data collected, 
“gating” is used to eliminate unwanted particles. For example, dead cells and debris 
usually have a lower FSC than living cells, so the gate will be drawn around higher FSC 
values indicating alive cells, thus removing the dead cells from the system to be 
analyzed. These gates are drawn until the population of interest is determined and a 
histogram is produced based on this analysis (Rahman, 2009).  
 
For this specific set of experiments, 7.2 mg of NPB (MW 3400 Daltons) powder is 
dissolved in 250µL of DMSO to obtain an initial concentration of 420µM. This 
concentration is then added to            MEF depleted mESCs for 10 minutes at room 
temperature. NPB remaining in solution, consequently not conjugated to a cell 
membrane surface, is washed out of the system using PBS. As a control,            
cells are also treated with 250µL of DMSO only. The mESCs in both conditions are 
resuspended in 2.35mL of ES Media and 2.35µl of LIF prior to splitting the cell 
suspension. 1mL (        cells) of the cell suspension is used for Day 0 studies while 
800µL (800,000 cells) of the suspension is plated in a second well plate for next day 
(Day 1) studies. 
 
For the imaging based approach, SAF488 is added to         cells for 10 minutes at 
room temperature in the dark. To remove unconjugated SAF488, the system is first 
rinsed with FACs buffer (PBS + 2% BSA) and then the fluorescently labeled cells are 
resuspended in 1mL of FACs buffer. This solution is then transferred to well plates 
before imaging.  
 
Similarly, for flow cytometry, SAF647 is added to         cells for 10 minutes at room 
temperature in the dark. Again, the system is washed with FACs buffer to remove 
unconjugated SAF647 and the cells resuspended in 1mL of FACs buffer. The cells are 
kept in suspension in a tube.  
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4.3 Results 
During flow cytometry, data is collected for 10,000 alive cells in a FSC-A vs SSC-A gate. 
The desired cell population is further obtained from gating the new cell population 
obtained from the first gating. The second gate is based on FSC-W vs FSC-A plot.  The 
resulting histogram can be seen in Figure 6a.  
 
Theoretically, mESCs treated with NPB should bind to cell surface amines through 
amide bonds between the cell membrane amine group and the biomaterial NHS group. 
This is idea is confirmed, as there is a noticeable shift in fluorescence when NPB 
(420µM) is added to the system compared to mESCs that did not receive this biomaterial 
dosage. However, there appears to be two peaks in the treated mESC histogram 
indicating heterogeneity in labeling and detection. During microscopy, there again is 
(e.g. X = Biotin) 
 
Fluorescent Readout 
 
NHS-PEG-X 
 
NH
2
 
Figure 5: NHS-based biomaterial conjugation to amines located on a mouse embryonic stem cell 
membrane. Using well known biotin-streptavidin chemistry, a fluorescent streptavidin is bound to 
the NHS-based biomaterial. The resulting fluorescence is captured by either flow cytometry or 
imaging methods. 
 
NH PEG-X 
O 
   = 
    
Legend: 
= SAF647 for flow cytometry 
   (or SAF488 for imaging) 
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noticeable fluorescence detection when NPB is introduced in the system (Figure 6b). 
Thus once again confirming the conjugation of NPB to mESC cell membranes. However, 
it is difficult to see the heterogeneity with fluorescent microscopy despite it being clearly 
shown with flow cytometry. At this specific concentration, there are no imaging or flow 
cytometry multiple day data. Prior to imaging on Day 1, majority of the mESCs were 
floating in the media solution rather than attaching once again to the MEF layer.  
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DMSO Only 
NHS-PEG-Biotin (420µM)       
A) 
B) 
Figure 6: NHS-PEG-Biotin (420µM) conjugated on mESC (      cells) cell membranes has 
detectable fluorescence on Day 0 using both a) flow cytometry methods and b) fluorescent 
microscopy  
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4.4 Discussion  
This inhibition of cell adhesion to the feeder layer and subsequent inhibition of cell 
proliferation indicates a cell “pegylation”.  The concentration of NPB is possibly so high 
that the PEG components of the linker on the mESC surface may be very close to one 
another and encapsulate the cell. This could also potentially mean that the components 
of the cell membrane surface which normally attach to the MEF layer are now blocked 
by the PEG components of the biomaterial linker. Thus, indicating a need to lower and 
optimize the NPB concentration added.  
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Chapter 5 Dosage-Dependent Effects on Labeling Efficiency 
5.1 Introduction  
As seen in the last section, NPB at 420µM does have a strong and detectable 
fluorescent signal, but it causes the cells to be “pegylated”. This cell pegylation 
negatively impacts cell viability over time, as the cells are not able to reattach to the MEF 
layer. To address this “pegylation” concern, we performed a dose-dependent response 
experiment to optimize the concentration of biomaterial added to the surface. We do this 
because a high concentration may alter biological functions of the cells and pegylation 
may occur again, while a low concentration may not make the necessary modifications 
for the desired impact. We chose to investigate four other concentrations using a serial 
dilution method to determine which concentration(s) would give us a detectable 
fluorescence on a single day. Our hypothesis, based on the previous initial conjugation, 
is that as the concentration of the biomaterial linker decreases, there should be fewer 
linkers conjugating to the mESC surface membranes, Figure 7, thus correlating to a 
decrease in fluorescence.  
 
5.2 Experimental Approach 
The process used to label the biomaterial on the mESC surface is similar to that of the 
schematic in Figure 5. For this specific set of experiments, 7.2 mg of NPB (MW 3400 
Daltons) powder is again dissolved in 250µL DMSO to obtain an initial concentration of 
420µM. Through serial dilutions, the following concentrations are obtained: 210µM, 
105µM, 52.5µM, and 26.3µM. Each concentration is added to            MEF depleted 
mESCs for 10 minutes at room temperature. NPB remaining in solution is washed out of 
the system using PBS. As a control,            cells are also treated with 250µL DMSO. 
The mESCs are resuspended in 2.35mL of ES Media and 2.35µl of LIF. 1mL (        
cells) of cell suspension is pulled out for Day 0 studies. 
 
For the imaging based approach, SAF488 is added to         biomaterial labeled and 
control cells for 10 minutes at room temperature in the dark. To remove unconjugated 
SAF488, the system is rinsed with FACs buffer. The mESCs are resuspended in 1mL of 
FACs buffer and the solution transferred to well plates prior to imaging.  
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Similarly for flow cytometry, 10µL of SAF647 is added to both biomaterial labeled and 
control cells (        cells each) for 10 minutes at room temperature in the dark. To 
remove unconjugated SAF647, the system is rinsed with FACs buffer. The mESCs 
(       ) for each condition are then resuspended in 1mL of FACs buffer and used for 
flow cytometry.   
 
 
5.3 Results 
During flow cytometry, data is collected for 10,000 alive cells in a FSC-A vs SSC-A gate. 
The desired cell population is further obtained from gating the new cell population 
obtained from the first gating. The second gate is based on FSC-W vs FSC-A plot.  The 
cell population from the second gating is used to draw the histograms in Figure 8.  
 
As can be seen in the flow cytometry histograms in Figure 8, the four concentrations are 
shifted towards the right when compared to the DMSO only control, indicating both a 
detectable and high level of fluorescence. It is also seen that as the dosage of the NHS-
based biomaterial linker added decreases, so does the level of fluorescence.  This 
shows that there may in fact be fewer biomaterial linkers conjugating to the cell surface 
as the concentration of linker added to the system decreases, all conditions contain the 
same number of cells, as initially predicted. 
 
With imaging, higher levels of fluorescence are seen as the mESCs are treated with the 
NPB compared to the mESCs which simply have DMSO added to them. For example in 
Figure 7: A schematic displaying a decrease in dosage of biomaterial (NPB) added may 
correlate to a decrease of biomaterial conjugation to the mESC surface membrane 
= SAF647 for flow cytometry 
   (or SAF488 for imaging) 
   
210µM 105µM 52.5µM 
 
NH PEG-X 
O 
   = 
     
Legend: 
(e.g. X = Biotin) 
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Figure 9, in the DMSO only image, there is some background noise, but in the image 
with the mESCs treated with NPB at 105µM, there is a significant increase in 
fluorescence levels.  
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DMSO Only 
NHS-PEG-Biotin (26.3µM) 
NHS-PEG-Biotin (52.5µM) 
NHS-PEG-Biotin (105µM) 
NHS-PEG-Biotin (210µM) 
Figure 8: Using flow cytometry, there is a noticeable dosage dependent response. There is a 
decrease in fluorescence as the dosage of NPB added decreases, thus indicating a decrease in 
NPB binding to the mESC surface membrane. The four different dosages added are all detectable 
by flow cytometry on Day 0 
Untreated (DMSO only) Treated at 105µM 
B A 
Figure 9: The fluorescence is also detectable by imaging on Day 0. For example, the DMSO only 
control (no NPB added) shows some background signal, but the mESCs treated with NPB at 
105µM shows a significant increase in fluorescence levels compared to the control mESCs 
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5.4 Discussion 
With the dosage dependent response experiments (Figure 8), it is seen that even at the 
lowest concentration of biomaterial linker (26.3µM), there is still a detectable level of 
fluorescence, indicating cell surface modifications. The lower dosage does have a lower 
level of detectable fluorescence when compared to the higher dosage treatments 
indicating fewer surface modifications comparatively. This in turn correlates to the 
mESCs being closer to a “natural” state. At these concentrations, specifically for 105µM 
and lower, there is less negative cell viability as there are more alive cells during the 
gating procedure.  
 
Since it is not possible to determine the exact amount of mESC surface modification with 
flow cytometry, we use a Biotin Quantitation Kit (Thermo Scientific) in combination with a 
plate reader. Since this is a fairly sensitive assay, we decided to use NPB at 105µM 
since has less negative cell viability but yet a strong and detectable fluorescence level. 
We determined that 14.7pmol/10µL of NHS-based biotin binds to the surface of mESCs. 
 
Now that we have a range of NPB dosages which fit our criteria, with an exact optimal 
concentration, the new question that arises is how do mESCs treated with 105µM 
behave when they are replated over multiple days. 
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Chapter 6 Retention of Biomaterial Labeling in Self-Renewing ES Culture 
6.1 Introduction  
As discussed in Chapter 4, despite NPB at 420µM having a strong and detectable 
fluorescent signal on Day 0, replated mESCs in culture do not reattach to the MEF layer 
as the cells experience “pegylation”. This cell pegylation negatively impacts cell viability 
over time. To address the “pegylation” concern, we build upon the previous Chapter’s 
findings. In this section, we determine how NPB is retained over multiple days, 
specifically when NPB is added at 52.5µM and 105µM. These dosages are chosen 
because they both have a high level of fluorescence detection compared to the control 
and are at least 4x less than the initial dosage studied which should reduce “pegylation” 
effects from the beginning considerably. Our hypothesis based on Chapter 4, is that if 
the mESCs do not experience “pegylation,” the fluorescence should be similar over 
multiple days with minimal negative effects on the cells. 
 
6.2 Experimental Approach 
The process used to label the biomaterial on the mESC surface is similar to that of the 
schematic in Figure 5. 7.2 mg of NPB (MW 3400 Daltons) powder is again dissolved in 
250µL DMSO to obtain an initial concentration of 420µM. Using serial dilutions, NPB 
concentrations of 105µM and 52.5µM are attained. These concentrations are added to 
           MEF depleted mESCs for 10 minutes at room temperature. NPB remaining 
in solution is washed out of the system using PBS. As a control,            cells are 
also treated with 250µL DMSO. The mESCs are resuspended in 2.35mL of ES Media 
and 2.35µl of LIF and then divided for three different conditions. 1mL (        cells) of 
cell suspension are used for Day 0 studies, 800µL (800,000 cells) are plated in a second 
well plate for next day (Day 1) studies, and finally, 400µL (400,000 cells) are plated in a 
third well plate for Day 2 studies. 
 
For fluorescent imaging, SAF488 is added to both         biomaterial labeled and 
control cells for 10 minutes at room temperature in the dark. To remove unconjugated 
SAF488, the system is rinsed with FACs buffer. The mESCs are resuspended in 1mL of 
FACs buffer and the solution replated in well plates prior to imaging. For Day 1 
experiments, the mESCs are kept on the MEF layer in the well plate and washed with 
PBS after media removal (ensuring that any unattached cells and debris were out of the 
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system). SAF488 is introduced and incubated with the cells for 10 minutes in the dark at 
room temperature. The system is washed with FACs buffer to remove any unconjugated 
SAF488. 1.5mL of FACs buffer is added to the well plates and the cells are imaged. On 
Day 2, the cells are not imaged based on the results from Day 1.  
 
Similarly for flow cytometry, 10µL of SAF647 is added to         biomaterial labeled 
and control cells for 10 minutes at room temperature in the dark. To remove 
unconjugated SAF647, the system is rinsed with FACs buffer. 1mL (        cells) of the 
cell suspension is used for Day 0 studies. On Days 1 and 2, the cells are again 
trypsinized in the well plates. 10µL of SAF647 is added to the cell suspensions for 
10 minutes at room temperature in the dark, and again, unconjugated SAF647 is 
washed from the system using FACs buffer. The mESCS (       ) are resuspended in 
1mL of FACs buffer each time and used for flow cytometry.   
 
6.3 Results 
During flow cytometry, data is collected for 10,000 alive cells in a FSC-A vs SSC-A gate. 
The desired cell population is further obtained from gating the new cell population 
obtained from the first gating. The second gate is based on a FSC-W vs FSC-A plot.  
The cell population from the second gating is used to draw the histograms in Figure 10.  
 
Since we are able to detect fluorescence at Day 0, as seen in the previous Chapter and 
in the right-most histogram in Figure 10a, and there is no significant negative cell 
viability, the question of whether or not these particular concentrations result in cell 
“pegylation” arises. From a simple glance at the cells in the well plates on Days 1 and 2, 
there appear to be more mESC attachment onto the MEF layer and fewer floating cells 
as the biomaterial dosage decreases. As seen in Figure 10, this observation is 
confirmed with both flow cytometry and imaging methods.    
 
For the multiple day treatments, it is seen that with flow cytometry (Figure 10a), the 
fluorescence reading is detectable for both Days 1 and 2. However, with imaging 
(Figure 10b), a fluorescence signal is not seen as clearly on Day 1, and by Day 2, there 
is no detectable signal at all. Interestingly, it is seen that there is a clear decrease in the 
fluorescence level over the course of the three days. Day 0 has the highest fluorescence 
while by Day 2 the fluorescence level is similar to the untreated control condition. This 
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decrease is quantified in Figure 11, for NPB at 52.5µM, where we look at the log 
average relative fluorescence, based on the geometric mean, for Day 0, Day 1, and Day 
2 in respect to Day 0. For Day 1, the average relative fluorescence mean is 1.07± 0.01 
and for Day 2, it is 1.08 ± 0.002.  
 
Even though we found a range of dosages that do not appear to display negative cell 
viability over time and have detectable fluorescence levels, there is a significant 
unexpected decrease in fluorescence as conjugated mESCs are replated for Day 1 and 
Day 2 studies. This decrease in fluorescence could potentially be explained by two 
reasons: 1) the replated mESCs are splitting into daughter cells or 2) due to physical 
and/or chemical effects.  
 
When mESCs are replated, the biomaterial linkers are possibly dividing amongst 
daughter cells when the original conjugated parent cell divides. As a result, there are 
fewer linkers conjugated on a single mESC surface and thus a lowered fluorescence 
output. In regards to the latter reason, there could be a possibility that the linkers are 
falling off of the cell over the course of multiple days because the conjugation may not 
be as strong or the linkers could be recycled during normal cellular processes. Again, 
indicating fewer linkers conjugating to mESC surface membranes. To investigate this 
occurrence, we used a CFSE Cell Proliferation Kit (Life Technologies) and a drug 
(STLC).  
 
The CFSE dye labels a cell to trace multiple generations with flow cytometry. It is known 
to have long-term signal stability and should be non-toxic. By using a similar idea to our 
previous findings, the fluorescent signal from the CFSE dye should be the highest on the 
first day. As the days progress, there should be a sequential “halving” of the signal as 
the parent cells are being split into daughter cells (Matthias, 2011). If this pattern is 
observed, then it also indicates that the biomaterial linker is being split between daughter 
cells.  
 
STLC on the other hand, blocks the proliferation cycle and the parent mESC is not able 
to divide into daughter cells once it has been replated on a MEF layer. When cells on 
Days 1 and 2 are observed, and the cells have not been dividing, the cells should 
theoretically retain a similar level of biomaterial conjugation and fluorescence levels as 
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the cells from Day 0. If there is a slight or even a noticeable decrease in fluorescence, 
this could possibly indicate that the decrease is due to cell turnover or the biomaterial 
linker falling off over time. 
 
However, when these experiments were performed (data not shown), high levels of cell 
toxicity is observed. There is little cell attachment over the multiple days and more dead 
cells noticed during flow cytometry gating than previously seen. 
Control: DMSO Only 
Day 0: NHS-PEG-Biotin (105 µM) 
Day 1: NHS-PEG-Biotin (105 µM) 
Day 2: NHS-PEG-Biotin (105 µM) 
A) 
Day 0 Day 1 
B 
B) 
Figure 10: a) There is detectable fluorescence over the course of 3 days, but the fluorescence 
does decrease each day. By Day 2, the fluorescence for NPB treated mESCs is starting to overlap 
with the fluorescence histogram for the control mESCs, indicating a decrease in NPB linkers 
conjugating to cell membrane surfaces. b) There are detectable levels of fluorescence only on Day 
0 with imaging. Day 1 images show a fluorescence signal comparable to background fluorescence 
levels as seen in the DMSO only control. Imaging methods does not appear to be as sensitive of 
an approach as flow cytometry for our purposes 
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6.4 Discussion 
Based on the dosage dependent experiments (Figure 8), it is seen that NPB dosages at 
52.5µM and 105µM have high detectable levels of fluorescence. In this Chapter, we see 
that these are in fact optimal dosages to use as there is less negative cell viability and 
greater mESC reattachment to the MEF layer on Days 1 and 2, thus addressing the 
pegylation concerns.  
 
We also notice that it is difficult to observe NPB (at 105µM) fluorescence on Day 1 with 
imaging methods, but we are still able to detect fluorescence until Day 2 using flow 
cytometry. This indicates that imaging is not as sensitive of an assay as is required for 
these studies and that flow cytometry is the better method to utilize.  
 
Based on both the imaging and flow cytometry results, there is a noticeable decrease in 
fluorescence over the multiple days. To determine the reason behind the loss of 
fluorescence in self-renewing mESC culture, we used both CFSE and STLC, but neither 
method is successful in these experiments. In the future, it is important to analyze either 
the loss or the partitioning of linkers with an alternative method or through optimization of 
a different mitotic inhibitor. 
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Figure 11: Quantitative analysis showing a decrease in average relative fluorescence over three 
days when NPB is at 52.5µM. This is the same pattern which was seen using flow cytometry for 
NPB at 105µM 
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Chapter 7 Acrylate-Based Membrane Conjugation & Retention  
7.1 Introduction  
Based on the previous chapters, we have been able to confirm and optimize NPB 
conjugation to mESC cell surfaces. There are still some components which require 
further investigation, but for now, we now shift our attention to the next aim. To reiterate, 
our goal for the second aim is to explore the capability of modulating cell-biomaterial 
interactions through the addition of acrylate domains to the cell membrane. The NHS 
group in the biomaterial linker will bind to the amines on the surface as before, while the 
acrylate group interacts with another acrylate domain present in the solution via light 
polymerization, Figure 12. Through these interactions, a bond will form between two 
different biomaterial linkers with one of these linkers already conjugated to the cell 
surface membrane. This will serve as an initial testing phase prior to investigating cell-
cell interactions. 
 
Interestingly, from initial tests, we found that Acrylate-PEG-Biotin (APB) binds to the 
surface of mESC membranes readily, even in the presence of NHS-PEG-Acrylate (NPA). 
Even though NHS-based biomaterials usually have a greater affinity for binding to the 
functional groups compared to Acrylate-based biomaterials. We decided to explore and 
discuss this unexpected finding further in this Thesis. Similarly to NPB, we observe how 
APB interacts with the cell surface over the course of multiple days.  
 
Simultaneously, we are interested in further understanding where APB conjugates on 
the stem cell surface; specifically, whether it binds primarily to amine or to thiol groups. 
The best way to address this question is to use blocking reagents. By using two different 
blocking reagents, one that blocks amine groups (mPEG-NHS) and another which 
blocks thiol groups (mPEG-Malemide), we can investigate how the fluorescence differs 
compared to conditions where a biomaterial linker is added but not a blocking reagent.  
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7.2 Experimental Approach 
The overall process used to label the biomaterial on the mESC surface is similar to that 
of the schematic in Figure 5. However this time, we substitute the NPB biomaterial linker 
with APB (MW 5000Da). Specifically, we dissolve 7.2 mg of APB powder in 250µL 
DMSO to obtain an initial concentration of 495.6µM. Using serial dilutions, the following 
dosages are obtained: 247.8µM, 123.9µM, 61.95µM, 31µM, 15.5µM. 123.9µL of each 
dosage is added to approximately            MEF depleted mESCs for 10 minutes at 
room temperature. After 10 minutes, unconjugated APB remaining in the solution is 
rinsed out of the system using PBS. As a control,            cells are also treated with 
123.9µL DMSO, no biomaterial linker is added to these cells. Both biomaterial linker 
treated and the control mESCs are resuspended in 2.35mL of ES Media and 2.35µl of 
LIF and split for two different conditions. 1.55mL (           cells) of cell suspension is 
used for Day 0 studies and 800µL (800,000 cells) replated in a well plate for next day 
(Day 1) studies. 
 
Since imaging was determined to not be as sensitive of a technique as flow cytometry 
for our specific system, we now focus mainly on a flow cytometry based approach. 
Similar to previous experiments, 10µL of SAF647 is added to            cells in 
suspension for 10 minutes at room temperature in the dark. To remove unconjugated 
SAF647, the system is rinsed with FACs buffer. 1mL (         cells) of the cell 
suspension (APB binds to both the mESC surface and to SAF647) is required for Day 0 
studies. On Day 1, the cells are trypsinized from the well plates and MEF depleted once 
Light Polymerization  
 
Light 
 
= NHS-PEG-Acrylate 
                  
Legend: 
= Acrylate-PEG-Biotin 
                  
Figure 12: Schematic of modulating cell-biomaterial interactions using mESCs, acrylate 
domains, and light polymerization 
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again. 10µL of SAF647 is added to         cells for 10 minutes at room temperature in 
the dark. Again, unconjugated SAF647 is rinsed from the system with FACs buffer. The 
mESCS (       ) are resuspended in 1mL of FACs buffer and used for flow cytometry.  
On both days, 10µL of Propidium Iodide (PI) dye is added to the cell suspension. PI dye 
is taken up by dead cells and allows one to gate around the alive cells. This will allow for 
better understanding and quantification of cell viability.  
 
We also investigated the effects of blocking amine or thiol functional groups on mESC 
cell surfaces. The process is similar to above except we now first introduce either an 
amine or a thiol blocker onto the mESC cell surface. We dissolve 20mg of both the 
mPEG-MAL and the mPEG-NHS powders (separately) into 1000µL of DMSO to obtain a 
final concentration of 991.2µM for both. These blocking solutions are added to           
MEF depleted mESC cells for 20 minutes at room temperature. After time is completed, 
remaining blocking reagents in the solution are rinsed out of the system using PBS. As a 
control,           cells are also treated with 1000µL of DMSO. The control and blocking 
reagent treated mESCs are both resuspended in 1.73mL of PBS and split for two 
different conditions (addition of APB or no addition of APB).  
 
Specifically, we dissolve 10mg of APB powder in 1000µL DMSO to obtain an initial 
concentration of 247.8µM. This concentration is further diluted to obtain the final dosage 
of 123.9µM. This dosage (123.9µL) is added to approximately            mESCs 
(DMSO only control, mPEG-NHS treated, and mPEG-NHS treated) for 10 minutes at 
room temperature. Remaining APB in the different conditions are washed out of the 
system using PBS and resuspended once again in 2mL of PBS. The control DMSO only 
treated mESCs,            cells, receive 123.9µL DMSO. The steps for addition of 
SAF647 and mESC preparation for flow cytometry are the same as above. 
 
7.3 Results 
During flow cytometry, data is collected for 10,000 alive cells in a FSC-A vs PE-Cy5.5-A 
gate. To ensure that only alive cell data is analyzed at the end, the population from the 
FSC-A vs PE-Cy5.5-A gate is further gated with FSC-A vs SSC-A. This population is 
finally gated based on FSC-W vs FSC-A, thereby achieving the final desired population.  
The cell population from the third gating is used to draw the histograms in Figures 13, 
14, 15, and 16. 
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For Day 0 studies, it can be seen that there is an incremental decrease in 
fluorescence/labeling as there is a decrease in the concentration of APB added into the 
system (from right to left in Figure 13). This observation is further confirmed by Figure 
14a, where there is a greater average relative fluorescence for APB at 124µM than at 
62µM when normalized to the DMSO only control. Interestingly, even at 15.5µM, which 
is 16 times less than the highest concentration in the histogram profile, the fluorescent 
signal is still greater than when only DMSO is added to the mESCs. Comparing fold 
increase in percent of dead cells data obtained from the PI dye, it is seen that the 
addition of APB to mESCs has only a slight increase in the percent of dead cells. This 
indicates that APB does not greatly affect the cells’ viability negatively.  
 
Similar to the NPB experiments, we want to observe how APB is retained on the mESC 
surfaces over multiple days. From general observations, it is seen that there is less 
mESC attachment on the MEF layer when mESCs are replated for Day 1 studies as the 
concentration of APB increased. On Day 0 (at 123.9µM), it can be see that there is a 
strong fluorescent detection when compared to the DMSO only treated condition. On 
Day 1, there is a great decrease in fluorescence levels and the APB treated histogram 
overlaps with the DMSO only control histogram.  
 
As seen in Figure 16a and 16b, the histograms for both the control (DMSO only) and 
only addition of blocking reagent (no APB) overlap and display minimal background 
fluorescence. Similar to before, with the addition of APB, there is an increase in 
fluorescence detection. In the presence of APB and both of the blocking reagents, there 
appears to be a minimal decrease in the fluorescence. This decrease appears to be 
similar for both of the conditions.  
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DMSO Only 
Acrylate-PEG-Biotin (15.5 µM) 
Acrylate-PEG-Biotin (31 µM) 
Acrylate-PEG-Biotin (62 µM) 
Acrylate-PEG-Biotin (124 µM) 
Acrylate-PEG-Biotin (248 µM) 
A) 
A) 
B) 
Figure 14: a) The bar graph shows a decrease in average relative fluorescence with a 
decrease in APB dosage on Day 0. This is similar to what is seen with the flow cytometry 
histograms for Day 0. b) A chart displaying a minimal fold increase in percent of dead mESCs 
cells with addition of APB as compared to the DMSO only control again 
Figure 13: Similar to NPB, there is a dosage dependent decrease in fluorescence for APB on 
Day 0. Again, all five NPB dosages tested have a detectable fluorescence level with flow 
cytometry 
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Figure 15: a) There is detectable fluorescence on Day 0 when APB is conjugated on mESC 
surface membranes compared to the DMSO only treated control mESCs. b) It appears that 
there is a decrease in fluorescence for the same APB treated mESCs from Day 0 on Day 1; 
the histogram overlaps with the DMSO only control. However, it is interesting to note that the 
DMSO only control on Day 1 has shifted towards the right compared to the histogram for 
control cells on Day 0 despite Day 1 control cells originating from mESCs used on Day 0 
A) 
B) 
Day 0 DMSO Only 
Day 0 Acrylate-PEG-Biotin (124 µM) 
Day 1 DMSO Only 
Day 1 Acrylate-PEG-Biotin (124 µM) 
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Figure 16: As seen in the histograms produced by flow cytometry, there is a slight decrease in 
fluorescence with the addition of the two surface blockers, a) mPEG-Malemide and b) mPEG-
NHS, to mESC surface membranes compared to fluorescence levels with the mESCs only 
labeled with APB. This decrease could potentially elucidate which functional group, amines or 
thiols, Acrylate-based biomaterials are more likely to conjugate to on mESC surface 
membranes 
A) 
B) 
DMSO Only 
Acrylate-PEG-Biotin + mPEG-Malemide 
Acrylate-PEG-Biotin Only (124 µM) 
mPEG-Malemide Only 
DMSO Only 
Acrylate-PEG-Biotin + mPEG-NHS 
Acrylate-PEG-Biotin Only (124 µM) 
mPEG-NHS Only 
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7.4 Discussion 
Even though APB binds more readily to mESC surfaces, its fluorescence detection is not 
as strong as that of NPB, even if a similar or larger dosage is added. Although, similar to 
previous tests, there is a strong correlation between the concentration of biomaterial 
linker added to the surface and to its fluorescence detection, for both single day and 
multiple day studies. For APB, it appears that the highest concentration that can be on 
the mESC surface prior to saturating the surface is 248µM. Higher concentrations 
display a similar fluorescence profile to that of APB at 248µM. Using this information in 
conjugation with the observation of mESC attachment for multiple days, the optimal 
concentration for APB studies is 124µM.  
 
Based on literature research, one possible explanation for the binding of Acrylate-based 
biomaterial linkers to the cell surface is due to the occurrence of the Michael-type 
addition reaction. In this reaction, various Michael donors (amines, enolates, thiols, and 
phosphines) can react with different Michael acceptors ((meth)acrylates, 
(meth)acrylamides, malemides, acrylonitriles and cyanoacrylates) (Figure 17). This 
reaction benefits from mild reaction conditions and minimal by-product formation 
(Li, 2010). According to Li et al, it was found that to optimally accelerate the rate of this 
binding reaction, primary amines (in our case, amine groups located on the cell surface) 
act as catalysts at ambient temperatures thus producing product at a faster rate. A 
combination of Michael addition and photoinitiated radical curing leads to higher 
crosslink densities and functional group conversions (Mather, 2006). This could 
potentially be beneficial in the future for some applications of interest and would be 
interesting to study further.  
 
Again, using a plate reader with the Biotin Quantitation assay, we find that the 
concentration of APB (using the data from 248µM) is 11.2pmol/10µL. Although the 
number of thiol groups on embryonic stem cell surfaces was not found in literature, it has 
been shown that endothelial and fibrosarcoma cells have at least 15 cell surface proteins 
that contain free thiol groups (Sahaf, 2003). There are approximately 10 proteins on the 
endothelial cell surface which contain closely spaced thiols and the molecular masses of 
these proteins varied from 13 to 153kDa. On the fibrosarcoma cell surface, there are 
approximately 12 proteins which contain closely spaced thiols and the molecular masses 
of these proteins varied from 19 to 104kDa (Donoghue, 2000). 
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Based on the multiple day studies, it is apparent that APB tends to leave the system 
pretty quickly. There is a large decrease in fluorescence by Day 1. Although, it is 
interesting to note that there is a shift in the DMSO only control for Day 1 studies that 
has not previously been seen. This indicates that there possibly is some sort of cellular 
surface modification occurring between Day 0 and Day 1. Potentially, this surface 
modification may allow SAF647 to bind to mESC surfaces without actually needing a 
biomaterial linker to be present. This occurrence is not clear and requires further study. 
  
Although there is a decrease in fluorescence with the addition of the blocking reagents, 
this does not necessary make it clear whether APB is more likely to bind to thiol or 
amine functional groups. Presently, it appears that APB binds to both functional groups 
equally, but the fluorescence decrease is not significant enough to fully support this 
finding. In the future, it will be interesting to observe how the fluorescence is affected if 
both mPEG-Malemide and mPEG-NHS are conjugated on the cell surface prior to the 
addition of APB. 
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Figure 17: Michael-type addition reaction between a) an acrylate group and primary amine 
group (Read, 2010) and b) an acrylate group and thiol group (Li, 2010) that could potentially 
explain the binding of APB to cell surface membranes. In the reaction in b), amines can also 
potentially act as catalysts in the acrylate-thiol reaction when forming the end product; in our 
case, it would be the binding of the Acrylate-based biomaterial to a mESC surface membrane 
B) 
A) 
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Chapter 8 Conclusion and Future Directions 
Currently, we have optimized both NHS-based biomaterial linkers and Acrylate-based 
biomaterial linkers for single day studies and only NHS-based biomaterial linkers for 
multiple day studies. The optimal dosage of NPB is 105µM while for APB, it is 124 µM. 
As discussed in this Thesis, there are still some questions which remain unanswered 
and require further study. In terms of the Acrylate-based multiple day studies, it is clear 
that there is a decrease in fluorescence by Day 1, based on previous data. However, it is 
not clear why the fluorescence level for the DMSO only control shifts to the right. This 
subtle ‘background signal’, which was most prominent in these experiments, needs to be 
studied further to understand why the DMSO treated only cells are displaying 
fluorescence when these mESCs did not receive any other treatment. It is also important 
to understand the reason behind the decrease in fluorescence levels in self-renewing ES 
cultures through either the analysis of the loss or the partitioning of linkers with 
alternative methods or through optimizing a different mitotic inhibitor. The other 
important question to address soon is to determine what cell surface functional groups 
are interacting with the acrylate-based biomaterials, and in particular, if the mechanism 
behind their membrane conjugation could be attributed to Michael’s addition reaction. 
Both of these questions could introduce potential new applications and may possibly 
affect in vivo studies.  
 
As discussed, stem cell membrane engineering is a relatively new field and holds great 
potential for further examination and the improved understanding of various cell 
membrane chemistries to use in a wide range of applications. Our particular work can 
lead the way in understanding cell-cell interactions by integrating our specific cell 
membrane engineering method with photopatterning techniques, such as 
stereolithography, in order to pattern multilayer cellular constructs. This engineered 3D 
system would allow for the controlled patterning of ES cells and the introduction of 
spatially heterogeneous mechanical cues. Particularly, non-uniform mechanical signals 
within multicellular systems have been demonstrated to play significant roles in cell 
differentiation, proliferation, and migration which one can also investigate. This allows for 
the probing of complex relationship between tissue geometries, mechanical stimuli, and 
stem cell differentiation. Regardless of the application pursued, it is clear that the 
implications and potential impact of stem cell membrane engineering on tissue 
engineering is tremendous and one step closer to fully realized in vivo applications. 
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